Low power methodology manual for system-on-chip design /

af Keating, Michael
Udgivet 2007.

A Unique Finger Injury in a Professional Hockey Player: A Case Report

af Keating, Michael J.
Udgivet 1999

Points from Letters: Synthetic Drugs and Carcinoma

af Keating, Michael J.
Udgivet 1964

Migratory Pruritus

af Keating, Michael J.
Udgivet 1960

Reuse methodology manual for system-on-a-chip designs /

af Keating, Michael, Bricaud, Pierre.
Udgivet 1999.

Naciones contra el Estado : el nacionalismo de Cataluña, Quebec y Escocia /

af Keating, Michael, Beltrán, Sordi.
Udgivet [1996

The significance of spliceosome mutations in chronic lymphocytic leukemia

af Rozovski, Uri, Keating, Michael, Estrov, Zeev
Udgivet 2013

Targeting Inflammatory Pathways in Chronic Lymphocytic Leukemia

af Rozovski, Uri, Keating, Michael J., Estrov, Zeev
Udgivet 2013

Blood collection methods affect cellular protein integrity: implications for clinical trial biomarkers and ZAP-70 in CLL

af Chen, Lisa S., Keating, Michael J., Gandhi, Varsha
Udgivet 2014

Pharmacokinetic and pharmacodynamic evaluation of ibrutinib for the treatment of chronic lymphocytic leukemia: rationale for lower doses

af Bose, Prithviraj, Gandhi, Varsha V., Keating, Michael J.
Udgivet i Expert Opin Drug Metab Toxicol (2016)

Pharmacotherapy of relapsed/refractory chronic lymphocytic leukemia

af Zahr, Abdallah Abou, Bose, Prithviraj, Keating, Michael J.
Udgivet i Expert Opin Pharmacother (2017)

Transcription inhibition by flavopiridol: mechanism of chronic lymphocytic leukemia cell death

af Chen, Rong, Keating, Michael J., Gandhi, Varsha, Plunkett, William
Udgivet 2005

Public Policy to Reduce Inequalities across Europe

af Cairney, Paul, Keating, Michael, Kippin, Sean, St Denny, Emily
Udgivet 2022

Fludarabine increases oxaliplatin cytotoxicity in normal and chronic lymphocytic leukemia lymphocytes by suppressing interstrand DNA crosslink removal

af Moufarij, Mazin A., Sampath, Deepa, Keating, Michael J., Plunkett, William
Udgivet 2006

Gossypol, a BH3 mimetic, induces apoptosis in chronic lymphocytic leukemia cells

af Balakrishnan, Kumudha, Wierda, William G., Keating, Michael J., Gandhi, Varsha
Udgivet 2008

Critical appraisal of the role of rituximab in the treatment of patients with previously untreated or treated chronic lymphocytic leukemia (CLL)

af Al-Kali, Aref, Wierda, William, Keating, Michael, O’Brien, Susan
Udgivet 2010

Personalized medicine in CLL: Current status and future perspectives

af Rozovski, Uri, Hazan-Halevy, Inbal, Keating, Michael J., Estrov, Zeev
Udgivet 2013

Importance of minimal residual disease in hairy cell leukemia: monoclonal antibodies as a therapeutic strategy

af THOMAS, DEBORAH A., RAVANDI, FARHAD, KEATING, MICHAEL, KANTARJIAN, HAGOP M.
Udgivet 2009

Pregnancy in a patient with hypereosinophilic syndrome

af Ault, Patricia, Cortes, Jorge, Lynn, Alice, Keating, Michael, Verstovsek, Srdan
Udgivet i Leuk Res (2008)

Preclinical combination of TP-0903, an AXL inhibitor and B-PAC-1, a procaspase-activating compound with ibrutinib in chronic lymphocytic leukemia

af Patel, Viralkumar, Keating, Michael J., Wierda, William G., Gandhi, Varsha
Udgivet i Leuk Lymphoma (2015)